Trump has a 'hunch' the COVID-19 death rate is 'way under 1 percent,' calls the WHO's 3.4 percent 'a false number'


On Tuesday, the World Health Organization announced that the mortality rate for the new COVID-19 coronavirus is higher than the original 2.3 percent estimate.
"Globally, about 3.4 percent of reported COVID-19 cases have died; by comparison, seasonal flu generally kills far fewer than 1 percent of those infected," WHO Director General Tedros Adhanom Ghebreyesus told reporters. "While many people globally have built up immunity to seasonal flu strains, COVID-19 is a new virus to which no one has immunity; that means more people are susceptible to infection, and some will suffer severe disease."
President Trump told Fox News host Sean Hannity on Thursday night that the WHO is probably wrong. "Well, I think the 3.4 percent is really a false number," he said. " Now, this is just my hunch, but based on a lot of conversations with a lot of people that do this." Because 11 people have died in the U.S., "all of a sudden is seems like 3 or 4 percent, which is a very high number, as opposed to a fraction of 1 percent," Trump added. "Personally, I would say the number is way under 1 percent."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Trump also explained why he wasn't concerned about the coronavirus at first, according to CNN's Daniel Dale.
At MSNBC, Chris Hayes discussed what the Trump administration failed to learn from China's coronavirus experience, primarily that "you have to be clear, honest, and transparent about the scope of the virus and the infection."
You can watch the entire Trump interview at Fox News.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Critics' choice: Outstanding new Japanese restaurants
Feature An all-women sushi team, a 15-seat listening bar, and more
-
Why do Dana White and Donald Trump keep pushing for a White House UFC match?
TODAY'S BIG QUESTION The president and the sports mogul each have their own reasons for wanting a White House spectacle
-
'Quiet vacationing': a secret revolt against workplace culture
The explainer You can be in two places at once
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts